Which statement about formulation details is correct?

• A. The excipients used in the formulation should be described and justified if clinically relevant
• B. The product's advertising strategy
• C. The trial's randomization method
• D. The source of packaging material

Answer: (A)

Describing a product’s formulation includes detailing all ingredients, including inactive ingredients (excipients), and explaining why each is there. Excipients can affect delivery, stability, tolerability, and safety, so if an excipient could influence clinical outcomes, it must be described and justified in the documentation. This helps ensure patient safety and allows proper assessment by sponsors, investigators, and regulators. The other options relate to advertising, study design, or packaging rather than what's inside the formulation, so they don’t address formulation details. Describing and justifying excipients when they are clinically relevant is the best fit.